European Pharmaceutical Review
JANUARY 9, 2024
Revolutionising quality control In the backdrop of stringent quality standards and regulatory demands inherent to pharmaceutical manufacturing, the addition of AI technologies introduce a paradigm shift. Integrative Analysis of Multi-Omics Data with Deep Learning: Challenges and Opportunities in Bioinformatics.
European Pharmaceutical Review
JUNE 6, 2023
Standard for antibiotic manufacturing to help combat AMR … Following this “ground-breaking standard” stated Courtney Soulsby, BSI Global Director for Healthcare Sustainability, the certification will “promote responsible pharmaceutical manufacturing and help protect the natural environment and slow antimicrobial resistance”.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
APRIL 11, 2024
Globally, the pharmaceutical sector emitted around 52 megatonnes of CO 2 in 2015, the most recent period for which detailed numbers are available. 1 Every major pharmaceutical manufacturer in the UK and Ireland is investing in making their operations and supply chains more environmentally friendly. 2019 Mar;214:185–94.
European Pharmaceutical Review
SEPTEMBER 28, 2023
When questioned about which technologies he considered have potential to advance the sector, Chornet emphasised that not only is mRNA as a vaccine technology “a very promising and interesting platform [but that it is] disruptive and a game changer technology for vaccine [manufacturing] and overall biotech.”
European Pharmaceutical Review
SEPTEMBER 29, 2022
The US Food and Drug Administration (FDA)’s Center for Drug Evaluation and Research (CDER) through the Office of Pharmaceutical Quality in 2021 embarked on an initiative to develop a framework for establishing a pharmaceutical manufacturing site quality rating system, the Quality management maturity (QMM) programme. April 2022.
European Pharmaceutical Review
AUGUST 17, 2022
million deaths in 2019 and been the direct cause of 1.27 What are the causes of AMR and how is the pharmaceutical industry implicated? Steve Brooks, Manufacturing Lead at the AMR Industry Alliance (Advisor to the Alliance): AMR is multifaceted; there are many potential causes, including environmental ones. The Lancet.
pharmaphorum
OCTOBER 26, 2022
Chiesi has proven its dedication to global public health through its designation as a certified Benefit Corporation (B Corp) since 2019. The status isn’t awarded lightly and Chiesi is the largest pharmaceutical manufacturer to be named a B Corp. “We About the author. The company aims at becoming net-zero by 2035.
Expert insights. Personalized for you.
122 
Let's personalize your content